0001493152-20-000166.txt : 20200103
0001493152-20-000166.hdr.sgml : 20200103
20200103191104
ACCESSION NUMBER: 0001493152-20-000166
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200101
FILED AS OF DATE: 20200103
DATE AS OF CHANGE: 20200103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schreiber Christopher C
CENTRAL INDEX KEY: 0001750076
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36268
FILM NUMBER: 20507630
MAIL ADDRESS:
STREET 1: AKERS BIOSCIENCES, INC.
STREET 2: 201 GROVE ROAD
CITY: THOROFARE
STATE: NJ
ZIP: 08086
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akers Biosciences, Inc.
CENTRAL INDEX KEY: 0001321834
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 GROVE RD
CITY: THOROFARE
STATE: NJ
ZIP: 08086
BUSINESS PHONE: 856-848-8698
MAIL ADDRESS:
STREET 1: 201 GROVE RD
CITY: THOROFARE
STATE: NJ
ZIP: 08086
FORMER COMPANY:
FORMER CONFORMED NAME: Akers Biosciences Inc
DATE OF NAME CHANGE: 20050325
4
1
ownership.xml
X0306
4
2020-01-01
0
0001321834
Akers Biosciences, Inc.
AKER
0001750076
Schreiber Christopher C
C/O TAGLICH BROTHERS INC
709 NEW YORK AVENUE.SUITE 209
HUNTINGTON
NY
11743
1
1
0
0
Executive Chairman
Common Stock
2020-01-01
4
M
0
5201
A
5201
D
Restricted Stock Units
2020-01-01
4
M
0
5201
0.00
A
Common Stock
5201
0
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Akers Biosciences, Inc. (the "Company").
On March 29, 2019, the reporting person was granted 5,201 RSUs of the Company, which vested on January 1, 2020.
/s/ Christopher C. Schreiber
2020-01-03